Crossmark

The potential role of HGF-MET signaling and autophagy in the war of Alectinib versus Crizotinib against ALK-positive NSCLC

Crossref DOI link: https://doi.org/10.1186/s13046-018-0707-5

Published Online: 2018-02-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Xing https://orcid.org/0000-0002-8886-2777
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81502975)

China Postdoctoral Science Foundation (2016T90413, 2015M581693)
More Information

Article History

Received: 9 January 2018

Accepted: 13 February 2018

First Online: 20 February 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The author declares that he has no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.